AI Federal Workplace Drug Testing Program Audit Playbook
A federal contractor's drug-free workplace program is subject to a compliance audit under the Drug-Free Workplace Act. The audit has flagged 4 findings: incomplete CCF records, expired collector certifications, no MRO verification of positive results within required timeframe, and missing random testing pool documentation.
When to use this playbook
- Use this playbook when the decision looks like the situation above: A federal contractor's drug-free workplace program is subject to a compliance audit under the Drug-Free Workplace Act.
- It is a fit when you have source files in hand and need a structured, reviewable analysis — not a generic chat answer about "Federal Workplace Drug Testing Program Audit".
- Do not use it as a substitute for licensed, legal, clinical, or authorized official judgment in the domain.
What you'll need
- Audit findings report (4 findings with citations)
- Program documentation: CCF records, collector certifications, MRO logs, random pool records
- HHS Mandatory Guidelines and DFWA requirements
- Agency contracting officer's response deadline
- Prior audit history
Attachments: Documents (Documents)
The Prompt
You are a drug testing compliance specialist responding to a Drug-Free Workplace Act audit for a federal contractor. I am attaching: Work only from the attached source files. If a conclusion is not supported, say so. Produce: 1. Assess each finding: what specific regulatory requirement was violated, is it a documentation error or a substantive compliance failure? 2. Prioritize the findings by severity: which creates the highest legal and contract risk? 3. Develop the corrective action plan for each finding with a timeline and recurrence prevention. 4. Draft the response to the contracting officer: acknowledge findings, present corrective actions, and provide a timeline without admitting additional liability. 5. Tell me whether any findings could trigger contract suspension or debarment and what the protective steps are. Call out where independent models are likely to disagree, and list follow-up documents a reviewer should request.
What to expect
- Per-finding violation assessment and severity classification
- Prioritized risk ranking
- Corrective action plan with timeline
- Contracting officer response draft
- Contract suspension/debarment risk and protective steps
Review before you act
- Validate this output against source files before relying on it: Assess each finding: what specific regulatory requirement was violated, is it a documentation error or a substantive compliance failure?.
- Validate this output against source files before relying on it: Prioritize the findings by severity: which creates the highest legal and contract risk?.
- Validate this output against source files before relying on it: Develop the corrective action plan for each finding with a timeline and recurrence prevention.
- Validate this output against source files before relying on it: Draft the response to the contracting officer: acknowledge findings, present corrective actions, and provide a timeline without admitting additional liability.
- Confirm every cited figure, date, counterparty, or requirement against the attached originals — models compress and can drop a qualifier.
- Treat disagreement between models as a review item, especially on classification, materiality, and recommended next action.
- Do not authorize an operational, clinical, legal, credit, or enforcement action solely because the models agree.
Why compare models on this
For Federal Workplace Drug Testing Program Audit, running the same attachments across independent models is useful because the hard part is classification and completeness, not fluency. The workflow is already designed to surface per-finding violation assessment and severity classification; prioritized risk ranking; corrective action plan with timeline; contracting officer response draft. Those are comparison artifacts — they only exist if more than one model runs. Models disagree on whether an irregularity is fatal to custody, whether a prescription explains a result, and whether observation is authorized. Those splits are MRO work, not auto-verification.
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

